696 related articles for article (PubMed ID: 32075803)
61. Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma.
Akkız H
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835352
[TBL] [Abstract][Full Text] [Related]
62. Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
Xing YF; Cai RM; Lin Q; Ye QJ; Ren JH; Yin LH; Li X
Kidney Int; 2017 May; 91(5):1236-1242. PubMed ID: 28215666
[TBL] [Abstract][Full Text] [Related]
63. Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts.
Kong J; Tian H; Zhang F; Zhang Z; Li J; Liu X; Li X; Liu J; Li X; Jin D; Yang X; Sun B; Guo T; Luo Y; Lu Y; Lin B; Liu T
Mol Cancer; 2019 Dec; 18(1):175. PubMed ID: 31796058
[TBL] [Abstract][Full Text] [Related]
64. Cancer-associated fibroblasts enact field cancerization by promoting extratumoral oxidative stress.
Chan JS; Tan MJ; Sng MK; Teo Z; Phua T; Choo CC; Li L; Zhu P; Tan NS
Cell Death Dis; 2017 Jan; 8(1):e2562. PubMed ID: 28102840
[TBL] [Abstract][Full Text] [Related]
65. Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Tousif S; Wang Y; Jackson J; Hough KP; Strenkowski JG; Athar M; Thannickal VJ; McCusker RH; Ponnazhagan S; Deshane JS
Front Immunol; 2021; 12():747780. PubMed ID: 34867973
[TBL] [Abstract][Full Text] [Related]
66. Expression of H
Alvear-Arias JJ; Carrillo C; Villar JP; Garcia-Betancourt R; Peña-Pichicoi A; Fernandez A; Fernandez M; Carmona EM; Pupo A; Neely A; Alvarez O; Garate J; Barajas-Martinez H; Larsson HP; Lopez-Rodriguez A; Latorre R; Gonzalez C
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2104453119. PubMed ID: 35377790
[TBL] [Abstract][Full Text] [Related]
67. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
68. Ganoderma lucidum polysaccharide (GLP) enhances antitumor immune response by regulating differentiation and inhibition of MDSCs via a CARD9-NF-κB-IDO pathway.
Wang Y; Fan X; Wu X
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32530032
[TBL] [Abstract][Full Text] [Related]
69. Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer.
Koinis F; Vetsika EK; Aggouraki D; Skalidaki E; Koutoulaki A; Gkioulmpasani M; Georgoulias V; Kotsakis A
J Thorac Oncol; 2016 Aug; 11(8):1263-1272. PubMed ID: 27178984
[TBL] [Abstract][Full Text] [Related]
70. The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment.
Monteran L; Erez N
Front Immunol; 2019; 10():1835. PubMed ID: 31428105
[TBL] [Abstract][Full Text] [Related]
71. Curcumin suppresses the proliferation and tumorigenicity of Cal27 by modulating cancer-associated fibroblasts of TSCC.
Ba P; Xu M; Yu M; Li L; Duan X; Lv S; Fu G; Yang J; Yang P; Yang C; Sun Q
Oral Dis; 2020 Oct; 26(7):1375-1383. PubMed ID: 32060973
[TBL] [Abstract][Full Text] [Related]
72. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
73. MDSC subtypes and CD39 expression on CD8
Koh J; Kim Y; Lee KY; Hur JY; Kim MS; Kim B; Cho HJ; Lee YC; Bae YH; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Eur J Immunol; 2020 Nov; 50(11):1810-1819. PubMed ID: 32510574
[TBL] [Abstract][Full Text] [Related]
74. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
75. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease.
Ju JM; Nam G; Lee YK; Jung M; Chang H; Kim W; Shon WJ; Lim JY; Kim JY; Chang J; Min CK; Lee DS; Choi K; Shin DM; Choi EY
Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649207
[TBL] [Abstract][Full Text] [Related]
76. TRAF4 promotes lung cancer aggressiveness by modulating tumor microenvironment in normal fibroblasts.
Kim E; Kim W; Lee S; Chun J; Kang J; Park G; Han I; Yang HJ; Youn H; Youn B
Sci Rep; 2017 Aug; 7(1):8923. PubMed ID: 28827764
[TBL] [Abstract][Full Text] [Related]
77. Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids.
Arora L; Kalia M; Roy S; Pal D
J Vis Exp; 2022 Oct; (188):. PubMed ID: 36342137
[TBL] [Abstract][Full Text] [Related]
78. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.
Porta C; Consonni FM; Morlacchi S; Sangaletti S; Bleve A; Totaro MG; Larghi P; Rimoldi M; Tripodo C; Strauss L; Banfi S; Storto M; Pressiani T; Rimassa L; Tartari S; Ippolito A; Doni A; Soldà G; Duga S; Piccolo V; Ostuni R; Natoli G; Bronte V; Balzac F; Turco E; Hirsch E; Colombo MP; Sica A
Cancer Res; 2020 Jul; 80(13):2874-2888. PubMed ID: 32265223
[TBL] [Abstract][Full Text] [Related]
79. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
80. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
